Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

NCT04392154

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Clinical Research Center of Alabama- Birmingham Birmingham, Alabama, United States
  • Investigate MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
View all 321 locations
View Trial Details
Completed

A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

NCT03822832

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Clinical Physiology Associates Fort Myers, Florida, United States
  • Finlay Medical Research Corp Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
View all 23 locations
View Trial Details
Completed

POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis

NCT05932654

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • First OC Dermatology - Fountain Valley Fountain Valley, California, United States
  • Center for Dermatology Clinical Research Fremont, California, United States
  • Profound Research LLC - Nashville - Corporate Oceanside, California, United States
  • The George Washington University School of Medicine and Health Science Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details

Related conditions